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Abstract
Cytomegalovirus’s (CMV’s) unique ability to drive the expansion of virus-specific T-cell
populations over the course of a lifelong, persistent infection has generated interest in the virus as
a potential vaccine strategy. When designing CMV-based vaccine vectors to direct immune
responses against HIV or tumor antigens, it becomes important to understand how and why certain
CMV-specific populations are chosen to inflate over time. To investigate this, we designed
recombinant murine cytomegaloviruses (MCMV) encoding a SIINFEKL-eGFP fusion protein
under the control of endogenous immediate early promoters. When mice were infected with these
viruses, T cells specific for the SIINFEKL epitope inflated and profoundly dominated T cells
specific for non-recombinant (i.e. MCMV-derived) antigens. Moreover, when the virus encoded
SIINFEKL, T cells specific for non-recombinant antigens displayed a phenotype indicative of less
frequent exposure to antigen. The immunodominance of SIINFEKL-specific T cells could not be
altered by decreasing the number of SIINFEKL-specific cells available to respond, or by
increasing the number of cells specific for endogenous MCMV antigens. In contrast, coinfection
with viruses expressing and lacking SIINFEKL enabled co-inflation of T cells specific for both
SIINFEKL and non-recombinant antigens. Because coinfection allows presentation of SIINFEKL
and MCMV-derived antigens by different cells within the same animal, these data reveal that
competition for, or availability of, antigen at the level of the antigen presenting cell determines the
composition of the inflationary response to MCMV. SIINFEKL’s strong affinity for H2-Kb, and
its early and abundant expression, may provide this epitope’s competitive advantage.
Introduction
Cytomegalovirus (CMV) establishes an asymptomatic latent or persistent infection, which is
characterized by the lifelong accumulation of a large number of virus-specific T cells. This
process is termed memory inflation, and has led to the exploration of CMV as a vaccine
vector for HIV and for tumor antigens, with significant initial success in the SIV model (1,
2). The fact that memory inflation occurs after infection with a single-cycle CMV (3)
indicates that CMV-based vaccines may be safely used even in immunosuppressed cancer
patients, further increasing the appeal of this approach. The vaccine potential of this virus
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has elevated the importance of understanding how inflationary CMV-specific responses are
selected and maintained during infection.
C57BL/6 mice mount a response to at least 20 viral antigens during acute infection with
murine CMV (MCMV) (4). Most of these responses, including those to the
immunodominant M45 antigen, then decline precipitously and leave small central memory
(TCM) populations. In contrast, memory inflation is dominated by only three responses:
those to M38, m139 and IE3, all of which are subdominant to M45 during acute infection
(5). These same three epitopes display memory inflation after infection with the single cycle
ΔgL-MCMV (3), which implies that non-productively infected cells harboring the viral
genome can drive memory inflation.
We presume that ongoing presentation of viral epitopes must be involved in memory
inflation. We have shown that memory inflation is sustained by repeated production of
short-lived effectors derived from a pool of memory cells established early in infection (6).
However, the reason that inflationary responses focus on just a few antigens is not well
understood.
MCMV has a highly ordered sequence of lytic cycle gene expression, which starts with the
transcription of Immediate Early (IE) genes and is followed by the synthesis of Early (E)
and then Late (L) gene products. However, latent MCMV infection in the lungs and liver is
characterized by sporadic expression of IE genes without evidence of E or L gene
expression (7, 8). This is thought to be abortive reactivation, in which the virus initiates the
standard lytic gene cascade, but gene expression is aborted at the IE stage (9). This scenario
predicts that IE gene products would be the most abundant during latent infection and thus
immunodominant, which is at least partly the case: IE3 becomes progressively more
immunodominant over time in B6 mice, and pp89 (IE1)-specific responses inflate somewhat
more than those specific for the E antigen m164 in BALB/c mice. Furthermore, recombinant
epitopes expressed behind IE promoters provoke inflationary responses (10). However, M38
and m139, both E antigens, also provoke immunodominant inflationary responses in B6
mice, as does m164 in BALB/c mice (5). Likewise in humans, T cells target epitopes
expressed with IE, E and L kinetics (11) and cells specific for the L gene product pp65 are
frequently immunodominant (12–14). The viral gene expression program that drives these
diverse responses is not yet clear.
Our data suggest that viral gene expression, and not productive replication, is sufficient to
promote inflation of T cells specific for E gene products. This is evidenced by the ability of
a single cycle ΔgL-MCMV to stimulate inflation of T cells specific for the E genes M38,
m139 and m164 (3). Abortive reactivation may sometimes proceed to expression of E genes,
as suggested by Simon et. al. (9). An alternate possibility is that a completely different gene
expression program occurs in some infected cells. Indeed, in the rat CMV heart transplant
model, expression of a subset of E genes without production of infectious virus has been
described (15). It is interesting that this “persistent” pattern of gene expression involved
very little IE gene expression. Similarly, expression of some viral genes in the absence of IE
gene expression is reported in monocytes latently infected with human CMV (16). Hence,
inflationary responses to E epitopes may be driven by different cells harboring a different
program of gene expression than those that drive the IE responses.
There is also some evidence that T cells can influence the pattern of immunodominance
during memory inflation. Indeed, Holtappels et. al. (17) described a “conditional”
immunodominant response specific for the viral m145 gene product in Balb/c mice, which
appeared when the immunodominant m164- and IE1-derived epitopes were deleted. In line
with this, Simon et. al. have suggested that T cells directly limit the cascade of viral gene
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expression (9). Thus, immunodominant T cell responses may restrict other epitopes from
being produced. Inflationary T cell responses of particularly high avidity, either due to
expression of high affinity T cell receptors (TCRs), or to abundant antigen expression, might
enforce a selective advantage by suppressing expression of additional epitopes.
Here, we describe memory inflation in response to recombinant MCMVs that encode a
SIINFEKL-GFP fusion protein under immediate early control. Not only did SIINFEKL
promote memory inflation, it became the sole inflationary epitope during chronic infection.
We used this model to explore the determinants of immunodominance in the inflationary T
cell response to MCMV.
Materials and Methods
Mice
C57BL/6 mice were purchased from The Jackson Laboratory. B6.SJL-CD45.1 congenic
(B6.SJL-Ptprca Pepcb/BoyJ) mice were also purchased from The Jackson Laboratory and
bred to C57BL/6 mice in house to generate CD45.1/CD45.2 F1 mice as recipients for
adoptive transfer experiments. OVA-Tg mice were bred from the B6.FVB-Tg(MMTV-neu/
OT-I/OT-II)CBnel Tg(Trp53R172H)8512Jmr/J strain to express the Erbb2/HER-2/neu
oncogene tagged with ovalbumin epitopes recognized by the OT-I and OT-II, but not the
Trp53 gene (18). Breeders of this strain were obtained from The Jackson Laboratory. Mice
were between the ages of 6 and 16 weeks upon infection. All studies were approved by the
Institutional Biosafety Committee and the Institutional Animal Care and Use Committee at
Oregon Health and Sciences University.
Virus Strains and Infections
Mice were infected i.p. with 2 × 105 PFU of virus, except in coinfection experiments, where
mice were infected with 1 × 105 PFU of each virus used. Virus labeled MCMV-WT BAC
was of the strain MW97.01, which is derived from a bacterial artificial chromosome of the
Smith strain (19). MCMV-GFP-SL8 and MCMV-GFP-MSL8 were generated on the
MW97.01 backbone. In both recombinant viruses, the SIINFEKL peptide plus 7 N-terminal
amino acids from ovalbumin (SGLEQLESIINFEKL, to facilitate normal peptide excision,
(20)) were fused to the C-terminal end of eGFP. In the case of MCMV-GFP-SL8, this fusion
construct was targeted to replace the m128 (IE2) gene, under the control of the IE2
promoter, using established techniques (21). In the case of MCMV-GFP-MSL8, the eGFP-
SL8 fusion construct was encoded with the Major Immediate Early promoter (MIEP) of
HCMV and targeted to replace exon 3 of the m128 gene in MCMV. Stocks of these viruses
were produced from murine embryonic fibroblasts and titered by plaque assay on Balb3T3s
without centrifugal enhancement.
To produce the ΔgL viruses, an ampicillin gene fragment was inserted into the M115 (gL)
gene of the MCMV-WT BAC (strain MW97.01, (22)) using homologous recombination.
Stocks of this virus were produced on gL-3T3 cells, which provide gL in trans (3), and
titered by plaque assay on gL-3T3s without centrifugal enhancement. The individual virus
stock used in figure 3 was checked for reversion by infecting murine embryonic fibroblasts,
a non complementing cell line, then passaging and monitoring these infected cells for 30
days. The growth of cells not infected by the initial inoculum confirmed the inability of the
this gL-deficient virus to spread from cell to cell.
Intracellular Cytokine Staining and FACS Analysis
For measurement of intracellular IFN-γ, peripheral blood was collected at the indicated time
points. Red blood cells were lysed with 3 ml of lysis buffer (150 mM NH4Cl, 10 mM
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NaHCO3) and the remaining cells were incubated for 5–6 hrs at 37°C in the presence of
10μM of the indicated peptide and brefeldin A (GolgiPlug; BD Pharmingen). Surface
staining was done overnight at 4°C, and cells were fixed and permeabilized for intracellular
cytokine staining with Cytofix/Cytoperm (BD Pharmingen). The following fluorescently
conjugated antibodies were used (CD8α [clone 53-6.7], CD27 [clone LG.7F9], CD3 [clone
145-2C11], CD127[clone A7R34], KLRG1 [clone 2F1], IFN-γ [clone XMG1.2]), and all
purchased from either BD Biosciences, eBioscience, or BioLegend. Samples were acquired
on an LSR II or a FACSCalibur (both BD) and analyzed with FLowJo software (Tree Star).
Adoptive Transfers
Splenocytes from congenic mice infected for 7 days with MCMV-WT BAC were harvested,
passed through a 70 μm cell strainer, washed twice with T cell media (RPMI 1640 with L-
glutamine + 10% FBS + 1% penicillin/streptomycin + 5 × 10−5 M β-mercaptoethanol) and
resuspended in PBS at 5 × 108 cells/ml. 100μl of this unfractionated splenocyte suspension
was injected into each congenic recipient via the retro-orbital route. These mice were
infected with either MCMV-GFP-SL8 or MCMV WT-BAC the following day.
RMA-S Peptide Binding and Stabilization Assays
For binding assays, TAP-deficient RMA-S cells were plated at 1×105 cells/well in 96-well
plates and cultured for 16 h at 25 °C in T cell media buffered with 25mM HEPES. The cells
were then washed with T cell media, incubated with different concentrations of the indicated
peptides at 25 °C for 2 hours, and then incubated for an additional 2 hours at 37 °C. After
this incubation, cells were washed once and stained on ice for 1 hour with PE-conjugated Y3
mAb, which binds to the class I MHC H-2Kb. The cells were then washed twice with PBS,
fixed with BD Fix/Perm solution, and analyzed on a BD FACSCalibur.
Quantitative Real-time PCR
1 × 106 murine embryonic fibroblasts were infected with WT MCMV or MCMV-GFP-SL8
at a multiplicity of infection of 10. Cells were harvested at 0, 1, 2, 3, 4, 8, 18, and 24 hours
post infection, and RNA was extracted using the Qiagen RNeasy Mini Kit (Qiagen). On-
column DNAse treatment was performed as described in the Qiagen protocol. cDNA was
generated using the Invitrogen SuperScript III First-Strand Synthesis SuperMix. A portion
of each sample was treated similarly, but without the addition of reverse transcriptase to
ensure that there was no DNA contamination. cDNA was then stored at −20 °C. Quantitative
PCR was performed using Platinum SYBR green qPCR SuperMix UGD with ROX, using
the primers at a concentration of 250nM. The samples were run on an ABI PRISM 7700
Sequence Detection System. Relative gene expression was determined by normalizing each
gene to β-actin, and comparing the gene expression relative to cells at 0 h. The calculations
were made following the method described in the User Bulletin Number 2: ABI Prism 7700
sequence detection system; subject, relative quanititation of gene expression (Applied
Biosystems). Primer sequences follow. SL8 F: ACGTAAACGGCCACAAGTTC, SL8 R:
TGAACTTCAGGGTCAGCTTG, IE3 F: GATTCAACCCGCCTGTTATG, IE3 R:
GATAATTCAGGCAGCCAACC, M38 F:TCGATATTGAGCTGCTTGA, M38 R:
CCCAGCCTGCAAGACTTC, m139 F: GCGCTCTGTGACAGAGTTT, m139 R:
ACGAGCAACAACATGGAA.
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Results
SIINFEKL-specific CD8+ T cells dominate memory inflation after infection with MCMV-GFP-
SL8
We generated a recombinant strain of MCMV expressing a GFP-SIINFEKL fusion construct
under the control of the endogenous MCMV IE2 promoter (Turula et. al., manuscript
submitted). After infection with this virus (MCMV-GFP-SL8), the SIINFEKL-specific CD8
T cell responses in B6 mice steadily inflated over time, becoming the dominant inflationary
T cell population in these animals at chronic time points (Figures 1A and B). We also
generated a virus in which the GFP-SIINFEKL fusion construct is under control of the
HCMV Major Immediate Early promoter (MCMV-GFP-MSL8), resulting in approximately
10–20 fold greater GFP fluorescence after in vitro infection (not shown). SIINFEKL-
specific T-cells dominated the inflationary response in mice infected with this virus as well
(data not shown). Responses to IE3- and M38-derived peptides were barely detectable in
these animals, whereas T cells specific for these epitopes each comprised approximately 5%
of the CD8 T-cell compartment in mice infected with WT MCMV (Figure 1A and (5)).
Notably, the size of M38- and IE3-specific T cell populations were similarly reduced when
measured as a frequency of all cells in the blood (not shown). Moreover, the proportion of
CD8+ T cells specific for M45, which are resting memory cells that do not inflate during
MCMV infection, were comparable in mice infected with either virus (Figure 1 and not
shown). These data indicate that proportional changes in T-cell numbers cannot explain the
disappearance of IE3 and M38 inflation. Thus, the presence of the SIINFEKL epitope and
the resulting T cell response suppressed inflation of IE3- and M38-specific T cells, despite
evidence that M38-specific T cells were successfully primed during acute infection.
SIINFEKL responses dominate memory inflation when SIINFEKL is expressed in a single
cycle MCMV
To determine whether the profound immunodominance of SIINFEKL would also occur in a
single cycle MCMV, we produced a version of MCMV-SL8-GFP lacking gL, a glycoprotein
necessary for cell entry and spread. The ΔgL-SL8 virus was confirmed to be spread-
deficient as described in the methods, but still induced SIINFEKL-specific T cells to inflate
and become dominant (Figure 1C), indicating that productive infection is not needed for the
immunodominance of this response.
Phenotype of cells specific for inflationary epitopes after infection with MCMV-GFP-SL8
Inflationary CD8+ T cells express KLRG1, and have low levels of the IL-7 receptor
(CD127) and the costimulatory molecule CD27 (6). This terminally differentiated effector
phenotype is consistent with recent or repeated antigen exposure. Conversely, T cells
comprising the memory response to non-inflationary epitopes M45 and M57 exhibit a
memory phenotype (KLRG1−, CD27+ and CD127+), which suggests that they are rarely
exposed to antigen after the acute phase of infection. Because responses to M38 and IE3
contract sharply after acute MCMV-GFP-SL8 infection, we wondered whether they would
also develop a memory phenotype.
Figure 2 shows that SIINFEKL-specific CD8’s at week 18 post infection exhibit the classic
phenotype of inflationary MCMV T cells, with upregulated expression of KLRG1 and
downregulation of CD27 and CD127. In contrast, T cells specific for M45 mostly lacked
KLRG1 and retained expression of CD127 and CD27, although some cells were KLRG1+.
This is similar to their phenotype in WT infection. Strikingly, the small M38-specific
population found in MCMV-GFP-SL8 infected mice had a similar phenotype to the M45-
specific cells: most cells lacked KLRG1, and retained CD27 and high levels of CD127. IE3-
specific cells were so infrequent that an accurate assessment of their phenotype was
Farrington et al. Page 5
J Immunol. Author manuscript; available in PMC 2014 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
impossible. These results suggest that SIINFEKL-specific cells have seen antigen recently
or repeatedly and that M45- and M38-specific cells encounter antigen rarely.
Altering the ratios of functional, epitope-specific cells available to respond to infection
does not influence the immunodominance of SIINFEKL-specific T cells
The precursor frequency of antigen-specific T cells - either naïve or memory - is a major
determinant of immunodominance during acute infections, and also affects proliferation and
memory CD8 T-cell lineage decisions (23). We wondered whether we could modify the
immunodominance of the SIINFEKL response during chronic infection by altering the ratios
of functional, epitope-specific CD8 T-cells prior to infection. We explored this possibility in
three ways.
First, we used mice that express OVA as a self-antigen behind the Mouse Mammary Tumor
Virus promoter. When these mice were infected with MCMV-GFP-MSL8, the acute
response to SIINFEKL was approximately one third of that in WT mice (Figure 3A),
consistent with a lower number of SIINFEKL-specific precursors. Nevertheless, during
chronic infection with either MCMV-GFP-MSL8 (not shown) or MCMV-GFP-SL8, the
SIINFEKL response inflated at the expense of the M38 and m139 responses (Figure 3A).
Next, we reduced the number of naïve CD8+ T-cells capable of responding to SIINFEKL
during acute infection by intravenous injection of SIINFEKL peptide prior to infection.
Intravenous peptide provides a large amount of antigen (signal 1) in the absence of
costimulation (signal 2), resulting in anergy or deletion of cognate T cells (24–26). Mice
were injected i.v. with 10μg of SIINFEKL peptide on each of the 3 days prior to infection.
SIINFEKL-specific T cells were not detected by ICS or tetramer staining 7 days post-
infection, indicating profound suppression and probable deletion of SIINFEKL-specific
cells, whereas T cells specific for MCMV epitopes were primed normally (Figure 3B).
However, by week 12, SIINFEKL responses had risen to the same percentage of total CD8s
as those of mice left untreated, and responses to IE3 and M38 were barely detectable (Figure
3B).
In a third experiment, we asked whether increasing the number of T cells available to
respond to IE3 and M38 would enable those responses to inflate after infection with the
SIINFEKL-expressing virus. Splenocytes from CD45.2+ donor mice that had been infected
with WT MCMV 7 days previously were adoptively transferred into CD45.1+CD45.2+ F1
naïve recipients. These mice were then infected with MCMV-GFP-SL8. A control group
received splenocytes from the same donors, but was infected with WT MCMV instead.
Figure 3C shows that the SIINFEKL-specific response still dominated memory inflation at
the expense of the IE3 and M38 responses. This was not because the transferred cells were
unable to proliferate, as the donor cells expanded and contributed to inflation in WT-
infected mice (Figure 3C). Thus, pre-expanding T cells specific for MCMV epitopes were
not able to override the profound immunodominance of SIINFEKL-specific CD8 T cells in
chronic infection.
Together these results suggest that the frequency of epitope-specific cells available prior to
infection is not the most significant factor in determining the size of the SIINFEKL response
relative to other MCMV responses during chronic infection with MCMV-GFP-SL8.
Competition for antigen shapes immunodominance during chronic MCMV infection
Because precursor frequency did not explain SIINFEKL’s dominance during chronic
infection, we asked whether the phenomenon was the result of competition between T-cells
at the level of the APC. This phenomenon has been termed immunodomination (27). To test
this, we co-infected mice with both WT MCMV and MCMV-GFP-SL8. Previous work has
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shown that co-infection with 2 viruses yields distinct foci of infection with each individual
virus (28). Thus, in our experiments, WT MCMV and MCMV-GFP-SL8 should largely
infect different cells within the same host and their epitopes should be presented to T-cells
by different APCs. This eliminates competition between T-cells of different specificities at
the level of the APC.
In mice receiving both viruses, responses to SIINFEKL and to the MCMV epitopes IE3 and
M38 were co-dominant during chronic infection (Figure 4A). We interpreted this to mean
that T cells specific for endogenous MCMV gene products were able to inflate when these
epitopes were not presented by APCs also presenting SIINFEKL. However, a trivial
explanation for this would be that a much faster replicating WT virus would result in a
greater abundance of MCMV epitopes in co-infected mice. Indeed, MCMV-SL8-GFP does
grow with slightly delayed kinetics in vitro (Turula et. al., manuscript submitted).
To ensure that this was not the case, we repeated these co-infection experiments with a
single-cycle virus, ΔgL-MCMV, in place of WT MCMV. Despite lacking gL, this virus can
still promote memory inflation during chronic infection (Figure 4B and (3)). Nevertheless,
in mice co-infected with MCMV-GFP-SL8 and ΔgL-MCMV, antigens from MCMV-GFP-
SL8 would clearly be more abundant. Figure 4B shows that at 18 weeks post infection,
responses to IE3, M38 and m139 were similar in co-infected mice and mice infected with
ΔgL-MCMV alone. These data indicate that the results in Figure 4A are not due to differing
rates of viral replication. We therefore conclude that competition at the level of the antigen
presenting cell influences inflation and immunodominance during MCMV infection.
SIINFEKL is expressed earlier and has a higher MHC binding affinity than endogenous
MCMV epitopes
The above data established that SIINFEKL is able to out-compete endogenous MCMV
epitopes to promote T-cell inflation when presented on the same APC. The mechanisms that
cause the immune system to narrowly focus T cell responses on a few immunodominant
epitopes are not completely understood. That being said, some factors are obviously
important: peptides that are more abundantly presented, either due to expression, processing,
or binding affinity, are more likely to be the focus of these responses (29, 30).
To compare the MHC binding affinity of SIINFEKL and the MCMV-derived inflationary
epitopes, all of which are presented by H-2Kb, we evaluated the ability of these peptides to
stabilize Kb on the surface of the TAP-deficient cell line RMA-S. Figure 5A shows that
SIINFEKL bound Kb most strongly, followed by M38 and m139, with IE3 binding with the
weakest affinity. Thus, a better ability to bind Kb would favor SIINFEKL presentation.
Epitope presentation is also affected by the amount of parent protein available for
degradation and presentation. Because SIINFEKL dominated memory inflation after
infection with the single cycle ΔgL-SL8, we presume that cells harboring the latent viral
genome, or their progeny, are responsible for the antigen presentation that drives memory
inflation. Since the identity of these cells is unknown, it is not possible to definitively
describe antigen synthesis and presentation at this site. However, as described above,
sporadic expression of IE genes in the absence of detectable E or L genes has been described
in latently infected lungs (7, 9). Preferential expression of IE genes is the likely explanation
for the immunodominance of IE-encoded antigens during memory inflation. In MCMV-
GFP-SL8, SIINFEKL is encoded behind the IE2 promoter and IE3 is driven by the Major
Immediate Early promoter. To explore the timing of expression of SIINFEKL, IE3, M38
and m139 during lytic cycle infection in vitro, we infected murine embryonic fibroblasts
with WT MCMV or MCMV-GFP-SL8, harvested RNA at various time points after
infection, and performed quantitative real time PCR. SIINFEKL was expressed immediately
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and abundantly; IE3 was also transcribed with immediate early kinetics, but probably less
abundantly, and, as expected, the E genes were expressed later (Figure 5B). These results
suggest that SIINFEKL may have a quantitative and kinetic advantage over IE3 in
expression during latency.
Discussion
We have shown that a GFP-SIINFEKL fusion construct, when inserted into MCMV under
immediate early control, completely dominates the inflationary memory response during
chronic infection with this virus. The number of SIINFEKL-specific T cells available prior
to infection was not the main determinant of immunodominance since the SIINFEKL
response was still dominant in mice expressing SIINFEKL as a self-antigen or after specific
peptide tolerization. Conversely, adoptive transfer to increase the number of T cells specific
for endogenous MCMV-derived peptides did not enable them to inflate in response to the
SIINFEKL-expressing virus. However, when mice were co-infected with WT MCMV and
our recombinant MCMV expressing SIINFEKL, inflationary responses developed to both
SIINFEKL and endogenous MCMV epitopes. This indicated that when different cells in the
same animal were infected with each of the individual viruses, and thus WT-infected APCs
were able to present MCMV epitopes without the competing influence of SIINFEKL, T
cells recognizing these epitopes were able to inflate alongside the SIINFEKL response. Yet,
when both sets of epitopes were encoded by the same virus and presumably expressed on the
same APC, T cells responding to SIINFEKL outcompeted the MCMV-specific responses.
This happened either because these cells had more antigen available to them or because they
were better able to access antigen. Thus, competition for - or availability of - antigen at the
level of the APC plays a significant role in the selection of inflationary responses during
chronic MCMV infection.
This competition may be won by the SIINFEKL response, at least in part, because patrolling
SIINFEKL-specific CD8+ T cells see antigen first and go on to terminate further gene
transcription. The silencing/desilencing and immune sensing hypothesis proposed by Simon
et. al. suggests that T-cells specific for the IE1-derived epitope in Balb/c mice prevent
further MCMV gene transcription. Consistent with this, only IE1 and IE2 transcripts have
been found in latently-infected lung tissue from Balb/c mice (8). IE3 and gB were found at
low levels only when the IE1 epitope was mutated such that it could no longer be presented
to T-cells (9).
Indeed, work from the Cicin-Sain group shows that the context of MCMV gene expression
influences whether or not an epitope generates an inflationary response (31). Dekhtiarenko
et. al. infected mice with one of two recombinant viruses expressing the gB epitope from
HSV-1, linked to the carboxy terminus of either IE2 or M45. Inflating gB responses were
seen only when expression was controlled by the IE2 promoter. When gB was linked to
M45, an E gene, gB T-cell responses dominated only during acute infection. This study
lends support to the idea that ordered, temporal viral gene transcription results in immune
recognition of the first viral gene products and immune silencing of downstream
transcription, resulting in a bias of the T-cell response toward IE antigens.
A similar scenario is likely at play in our system, where the IE2 promoter controls
SIINFEKL expression. In addition, SIINFEKL may be more abundant than other MCMV
epitopes as a result of higher MHC affinity and greater transcription levels. However, in
both the BALB/c model and the C57BL/6 model, inflationary memory consists of responses
to E-encoded antigens as well as IE-encoded antigens. This could be explained by the idea
that these responses are programmed to inflate from the time of acute infection, or by the
idea that E epitopes are presented by a different cell type during latency, one that is
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undergoing a different program of viral gene expression. However, our data argue against
both of these ideas. Inflationary responses are not programmed early during infection, as
MCMV-specific T cells transferred 7 days after infection did not inflate in a host later
infected with MCMV-GFP-SL8. Thus, repeated antigen exposure after priming is a
necessary driver of inflationary memory. In addition, different and simultaneous gene
expression programs are likely not the cause of E-gene-specific inflationary memory, as IE
and E responses were equally silenced by the expression of SIINFEKL under the IE2
promoter. Thus, we favor the hypothesis that competition between T-cell clones for antigen
at the level of the infected APC dictates the selection of epitopes that drive memory
inflation. This hypothesis implies that, after WT MCMV infection, IE1-specific T cells (in
Balb/c mice) and IE3-specific T cells (in B6 mice) fail to completely silence MCMV E-gene
expression.
When considering the use of MCMV and eventually HCMV as a vaccine vector, these
results emphasize the importance of gene expression kinetics and epitope availability in
determining the size of inflationary memory responses to individual antigens.
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Figure 1. SL8 is profoundly immunodominant over normal responses to MCMV
(A) C57BL/6 mice were infected i.p with the indicated MCMV viruses. Virus-specific T-
cells were measured in the blood at the indicated times post infection using intracellular
cytokine staining. (B) Individual responses from the two infections in part A are contrasted
at week 18 post infection. (C) Mice were infected with ΔgL-MCMV and CD8 T-cell
responses to the indicated epitopes were measured at Week 12 post infection using
intracellular cytokine staining. Individual plot points and bars represent 4–5 mice per group.
Experiments were done twice.
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Figure 2. Phenotype of SIINFEKL-specific and MCMV epitope-specific responses in chronic
infection
(A) Splenocytes from mice infected for greater than 18 weeks with the indicated viruses
were stained with SL8 or MCMV-specific tetramers and for the indicated surface markers.
The plots shown are gated on Tetramer+ CD8+ cells (black line) or Tetramer- CD8+ cells
(shaded histogram). Plots represent one mouse, which is representative of two experiments
with 3–4 mice per group. (B) Averages of the percent KLRG1 positive, percent CD27
positive, or CD127 mean fluorescence intensity of tetramer positive and tetramer negative
populations from the splenocytes collected in part A. Individual bars represent 3–4 mice per
group. Experiment was done twice.
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Figure 3. Precursor frequency does not contribute significantly to the immunodominance of
SIINFEKL-specific CD8 T-cell responses in chronic infection
(A) OVA Tg mice were infected i.p. with the indicated viruses. Virus-specific CD8 T-cells
were measured in the blood on day 7 and at week 18 post infection using intracellular
cytokine staining. (B) C57BL/6 mice were injected with 10μg SIINFEKL peptide i.v. on
days -3,-2 and -1 prior to infection with MCMV-GFP-SL8. Responses were measured in the
blood on day 7 and at week 18 post infection (C) CD45.2+, CD45.1+ naive recipients
received 2–5×107 unfractionated splenocytes from mice infected for 7 days with WT
MCMV. Recipients were infected with WT MCMV or with MCMV-GFP-SL8 and virus -
specific responses were measured in the blood at week 18 post infection. Total CD8 T-cell
responses are shown on the left and percentages of CD45.2-negative donor cells contributing
to either IE3 or M38 responses are shown on the right. Bars represent 4–5 mice per group.
Experiments were done twice.
Farrington et al. Page 14
J Immunol. Author manuscript; available in PMC 2014 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Competition for antigen shapes immunodominance during chronic MCMV infection
(A) C57BL/6 mice were infected i.p with WT MCMV and MCMV-GFP-SIINFEKL at the
same time. Virus-specific T-cells were measured in the blood at the indicated times post
infection using intracellular cytokine staining (B) Mice were infected i.p. with ΔgL MCMV
or both ΔgL MCMV and MCMV-GFP-SIINFEKL. Virus-specific CD8 T-cell responses
were measured in the blood at the indicated times post infection. The graph on the left shows
the T cell responses at the indicated weeks after co-infection. The graph on the right shows
the data from all groups at week 18. Individual bars represent 4–5 mice per group.
Experiments were done twice.
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Figure 5. MHC binding affinity of MCMV epitopes and kinetics of expression
(A) RMA-S cells were incubated with the indicated concentrations of peptide for 2hrs at
25°C and an additional 2hrs at 37°C, then washed and stained for H2-Kb expression.
Experiment was done twice. Shown is the normalized mean fluorescence intensity of class I
MHC on the surface of cells. (B) Murine embryonic fibroblasts were infected with the
indicated viruses and RNA was harvested at the time points listed on the y-axis. cDNA was
made in parallel with no reverse-transcriptase controls for each sample, and qRT-PCR was
done for the indicated gene products. No signal was obtained from the no reverse
transcriptase controls. Experiment was done twice.
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